483
Teva Parenteral Medicines, Inc.FDA 483 - Teva Parenteral Medicines, Inc. - August 30, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Teva Parenteral Manufacturing in Irvine, CA, was cited for multiple deficiencies during an FDA inspection. Key issues include failures in submitting NDA-Field Alert Reports, inadequate investigation of discrepancies and complaints, and insufficient employee training for visual inspection. Additionally, the firm lacked established procedures for preventing microbiological contamination, proper process validation, and adherence to laboratory control mechanisms.
Open in Dashboard
ID · c0bfa6e1-e202-45f2-a51e-ce981832063d